Posted on

“NOBODY Is Getting Off The Hook” – Donald Trump Gives Tariff Update

Donald Trump said, “nobody is getting off the hook” for the “unfair Trade Balances, and Non Monetary Tariff Barriers” that have been used against the United States.

He added that there was no tariff exception announced but rather, “these products are subject to the existing 20% Fentanyl Tariffs.”

Trump also added that the administration is “taking a look at Semiconductors and the WHOLE ELECTRONICS SUPPLY CHAIN in the upcoming National Security Tariff Investigations.”

Truth Social:

NOBODY is getting “off the hook” for the unfair Trade Balances, and Non Monetary Tariff Barriers, that other Countries have used against us, especially not China which, by far, treats us the worst! There was no Tariff “exception” announced on Friday. These products are subject to the existing 20% Fentanyl Tariffs, and they are just moving to a different Tariff “bucket.” The Fake News knows this, but refuses to report it. We are taking a look at Semiconductors and the WHOLE ELECTRONICS SUPPLY CHAIN in the upcoming National Security Tariff Investigations. What has been exposed is that we need to make products in the United States, and that we will not be held hostage by other Countries, especially hostile trading Nations like China, which will do everything within its power to disrespect the American People. We also cannot let them continue to abuse us on Trade, like they have for decades, THOSE DAYS ARE OVER! The Golden Age of America, which includes the upcoming Tax and Regulation Cuts, a substantial amount of which was just approved by the House and Senate, will mean more and better paying Jobs, making products in our Nation, and treating other Countries, in particular China, the same way they have treated us. The bottom line is that our Country will be bigger, better, and stronger than ever before. We will, MAKE AMERICA GREAT AGAIN!

National Economic Council Director Kevin Hassett revealed that 130 countries are negotiating with Donald Trump on trade policy.

Hassett said, “The reciprocal act was basically, guys, if you come to the table and negotiate us with us and treat us the same way we treat you, then we’ll you’ll get your rate really low. And so right now 130 countries, 130 countries have responded, and we’re negotiating with them.”

Breitbart reported:

National Economic Council Director Kevin Hassett said Sunday on CNN’s “State of the Union” that the Trump administration was negotiating trade policy with 130 countries.

He added, “Now, on the trade policy, the whole point of the trade policy is to address the national emergency that we’re too dependent on foreign products in the U.S., especially if we were at a time of conflict and we’re doing something about that. The reciprocal act was basically, guys, if you come to the table and negotiate us with us and treat us the same way we treat you, then we’ll you’ll get your rate really low. And so right now 130 countries, 130 countries have responded, and we’re negotiating with them. And they’ve got their rate down to 10%. So, really, it’s almost a two-world system. There’s a process about China that’s very, very nascent, if at all, and then the process for everybody else. So the process for everybody else is orderly. It’s clear, people are coming to town with great, great offers.”

Donald Trump is fixing the American economy!

Posted on

President Trump’s Tariffs Drive Hope for Gold Retirement Investors

(Note: Thank you for supporting American businesses like the one presenting a sponsored message below and working with them through the links below which benefits Pro Trump News. We appreciate your support!)

As President Donald Trump continues to leverage tariffs for both negotiations as well as to level the playing field for trade, every financial asset class is getting affected. Some are seeing wild fluctuations while precious metals such as gold and silver are living up to their “safe haven” reputation.

There are always ups and downs, but the current trajectory has precious metals investors extremely hopeful for the future.

A wide variety of buyers, from central banks to individual retirees minding their IRAs, are watching the indicators closely and asking questions.

  • What is going on with U.S. Treasuries?

  • Will the stock market return to stability in weeks, months, or years?

  • How will a weakened dollar and rising bond market affect other investments?

  • Will China blink soon or will there be a protracted trade war?

An increasingly popular option is rolling over or transferring portions of retirement accounts into a Gold IRA. In times of economic uncertainty, gold and silver shine.

But not all gold companies are the same. In fact, there are key factors savvy investors should take into account before deciding on a gold partner.

Augusta Precious Metals has performed extensive research across the industry and compiled their company comparison into a free checklist that can help new and experienced investors alike make an educated decision on which company will best fit their individual needs.

Beyond these metrics, there are two crucial reasons why more Americans are partnering with Augusta Precious Metals.

First, they do not employ fearmongering or high-pressure sales tactics to drive their business. There may be uncertainty in the world today but there are also many reasons to be extremely hopeful of what’s to come. America has a bright future ahead and precious metals will play very important roles in helping Americans secure and advance their golden years.

Second, Augusta Precious Metals believes in integrity above profits. Every business wants to make money but principled businesses know it’s best when everyone involved wins. This is why Augusta Precious Metals is one of the only major gold IRA companies in the industry that does not employ “Free Silver Schemes.”

Augusta Precious Metals is honored to have an A+ rating with the Better Business Bureau.

The Trump Administration often says the “Golden Age for America” is coming. Augusta Precious Metals believes that gold and silver could help Americans take hold of their own golden age and they’re ready for you to explore the best ways to make it a reality.

Receive a Free Gold IRA Guide today!

(Note: The information provided by Pro Trump News or any related communications is for informational purposes only and should not be considered as financial advice. We do not provide personalized investment, financial, or legal advice.)

Posted on

The Miracle Drug That Joe Rogan and Mel Gibson Talked About

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Pro Trump News. We appreciate your support!)

Mel Gibson’s appearance on the Joe Rogan Experience and their discussion about a potential miracle cancer drug grabbed the attention of people across the globe.

According to the Economic Times,

In a candid conversation on comedian Joe Rogan’s podcast, the Braveheart star revealed that two of his close friends, who had been battling stage 4 cancer, experienced remarkable recoveries after using ivermectin and fenbendazole—drugs commonly employed to treat parasitic infections like roundworms and threadworms.

Gibson went on to make a bold statement, claiming that all three friends who tried these medications “don’t have cancer right now.” He emphatically added, “This stuff works, man.” While these claims have sparked interest, experts urge caution, as scientific evidence supporting the use of these drugs for cancer treatment remains in its infancy.

Some preliminary studies hint at potential benefits. For instance, ivermectin, when combined with other therapies, has been found to shrink tumors in early research, though such findings are yet to be validated by larger clinical trials. Similarly, fenbendazole—marketed under brand names such as Panacur and Safe-Guard—has shown promise in laboratory studies by halting the growth of certain aggressive cancer cells.

Watch:

While studies are scarce, ivermectin and mebendazole (the FDA-approved version of fenbendazole) have long shown that they are highly effective in treating parasites.

You can get compounded Ivermectin + Mebendazole TODAY – and that’s where The Wellness Company comes in!

  • Ivermectin and Mebendazole combine dual-action forces to effectively and quickly treat parasitic infections.

  • 90 Oral Capsules, each containing 25mg Ivermectin + 250mg Mebendazole.

  • The Gold Standardof safety and efficacy for eradicating parasitic infections when taken as directed by a TWC licensed provider.

Medication You Can Trust from a Trusted Source

The medical experts at The Wellness Company – like Dr. Peter McCullough and Dr. Kelly Victory – were leaders in the efforts to provide the public with accurate medical information during COVID. These experts have repeatedly shown that they prioritized the health and welfare of their patients over the bottom line of the big pharmaceutical companies.

Now, The Wellness Company is the only company in the world to prescribe compounded Ivermectin + Mebendazole, in a high-dose 90-day supply:

Ivermectin – Backed by science and honored with a Nobel Prize, Ivermectin delivers precise treatment against parasitic infections, ensuring effective care and well-being for your family with trusted precision.

Mebendazole – Trusted by healthcare professionals, Mebendazole targets and eliminates intestinal parasites with precision, ensuring your family’s health and well-being with proven efficacy and safety.

MYTHS & FACTS

Not surprisingly, big pharma is doing everything they can to demonize Ivermectin (just like they did during COVID) and Mebendazole. Here are the truths:

  1. Ivermectin is not a horse paste. Ivermectin has won the Nobel Prize for parasitic eradication in humans and is widely used in mammals.

  2. Mebendazole is for human use.Just like with Ivermectin, the biopharmaceutical complex has attempted to scare people in believing the Mebendazole isn’t safe for human use – that is absolutely not true. While Fenbendazole is only approved for pets and livestock, the FDA has approved Mebendazole for human use.

What Cancer Experts are Saying

The use of Ivermectin and Mebendazole is being advocated by global cancer experts like Dr. William Makis. Dr. Makis, who is one of the most influential cancer experts and medical freedom fighter, routinely treats cancer patients with Ivermectin and Mebendazole. Indeed, Dr. Makis’ Substack is chock full of success stories directly attributed to this combination!

Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.

Click to order Ivermectin and Mebendazole from The Wellness Company today!

Note: The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.

Posted on

Trump 2028 Could be a “Bonanza” for Investors

Note: The information provided here or in any related communications is for informational purposes only and should not be considered as financial advice. We do not provide personalized investment, financial, or legal advice. Pro Trump News benefits from purchases made through our sponsors.

As you may have heard, Donald Trump is planning to run for a THIRD term in 2028.

Recently he told NBC news he’s “not joking” about the possibility.

And it’s driving some people insane…

The New York Times breathlessly reports, “It cannot happen.”

While the Associated press agrees, “It would violate the Constitution.”

But former White House Advisor, Jim Rickards says – it’s not as crazy as you might think.

Not since the 1940s has a U.S. President served more than two terms.

That’s when FDR – Franklin Delano Roosevelt – won his FOURTH consecutive election.

Ever since, we’ve been told it will never happen again.

But as we speak, the groundwork is being laid for a third Trump Presidency.

How is this even possible?

While no one knows exactly what Trump is planning… Rickards says his next move could make all the difference.

President just made a brilliant move…

Unlike anything we’ve seen in close to a century.

It’s eerily similar to something FDR was able to accomplish back in the 1930s.

Recently I sat down with Rickards to get the full story.

As you’ll see, it traces back to the release of a massive national asset, worth an estimated $150 trillion.

We’ve posted a replay of this interview online, which you can view free of charge.

Just keep in mind, this is a time sensitive story – with major changes coming as soon as May 3rd.

Posted on

“They’re At It Again” – Trump Unloads On 60 Minutes

Donald Trump is not happy with 60 minutes.

Trump blasted 60 minutes over “two separate but highly inaccurate stories about ‘TRUMP.”

Trump also once again called them out over their interview with Kamala Harris.

Trump called for the FCC to “impose the maximum fines and punishment, which is substantial, for their unlawful and illegal behavior.”

Truth Social:

I just finished watching 60 Minutes, the FAKE News Show that was scandalously responsible for REMOVING a terrible and incompetently delivered answer, by failed Presidential Candidate Kamala Harris, to an interview on 60 Minutes, just prior to Election Day, and putting in its place a completely different answer to a completely different question, in order to make Kamala look “coherent.” Now tonight, with two separate but highly inaccurate stories about “TRUMP,” they’re at it again. The people at CBS Fake News just don’t get it!

Almost every week, 60 Minutes, which is being sued for Billions of Dollars for the fraud they committed in the 2024 Presidential Election with their Interview of Failed Presidential Candidate Kamala Harris, mentions the name “TRUMP” in a derogatory and defamatory way, but this Weekend’s “BROADCAST” tops them all. They did not one, but TWO, major stories on “TRUMP,” one having to do with Ukraine, which I say is a War that would never have happened if the 2020 Election had not been RIGGED, in other words, if I were President and, the other story was having to do with Greenland, casting our Country, as led by me, falsely, inaccurately, and fraudulently. I am so honored to be suing 60 Minutes, CBS Fake News, and Paramount, over their fraudulent, beyond recognition, reporting. They did everything possible to illegally elect Kamala, including completely and corruptly changing major answers to Interview questions, but it just didn’t work for them. They are not a “News Show,” but a dishonest Political Operative simply disguised as “News,” and must be responsible for what they have done, and are doing. They should lose their license! Hopefully, the Federal Communications Commission (FCC), as headed by its Highly Respected Chairman, Brendan Carr, will impose the maximum fines and punishment, which is substantial, for their unlawful and illegal behavior. CBS is out of control, at levels never seen before, and they should pay a big price for this. MAKE AMERICA GREAT AGAIN!

Donald Trump currently has a lawsuit against 60 Minutes over how they edited an interview with Kamala Harris during the campaign.

Breitbart reported:

Trump has an ongoing $20 billion lawsuit against “60 Minutes” for how it edited an interview with Democratic presidential candidate Kamala Harris last fall. The president claims it was edited in a way to make Harris look good, something the newscast denies. But there are ongoing reports that Trump’s lawyers and CBS’ parent company are involved in settlement talks.

Carr and the FCC have launched a parallel investigation of CBS News about the same case, one of several that it has undergone that also involve ABC News, NBC, PBS, NPR and the Walt Disney Co.

Despite the legal battle, “60 Minutes” has been unstinting in its coverage of Trump’s administration since he took office for a second term, particularly correspondent Scott Pelley. He traveled to Ukraine to conduct an interview with that country’s president, Volodymyr Zelenskyy, on the site of a Russian attack where nine children were killed earlier this month.

The Mainstream Media continues to be dishonest.

Posted on

Trump Reveals Daylight Savings Stance

Donald Trump called on the House and Senate to “push hard for more Daylight at the end of a day.”

He also added, “most importantly, no more changing of the clocks.”

Truth Social:

The House and Senate should push hard for more Daylight at the end of a day. Very popular and, most importantly, no more changing of the clocks, a big inconvenience and, for our government, A VERY COSTLY EVENT!!! DJT

Supporters of making daylight savings permanent point out that it will allow for more daylight at the end of the day.

The Hill reported:

Lawmakers have regularly introduced bills to make daylight saving time permanent, but the legislation has struggled to make it through both chambers of Congress.

Supporters of making daylight saving permanent, which would end the need for most Americans to turn the clocks back an hour in the fall, have argued it would allow for more sunlight later into the day, allowing people to enjoy the outdoors for longer. It’s also a popular proposal among golfers and golf course developers.

But critics of the shift have argued it would mean it would remain dark out later into the morning, forcing children to go to school, and in some cases wait for buses, in the dark.

Donald Trump is calling on Congress to take action!

Posted on

Trump Has Already Answered More Questions In Cabinet Meetings Than Biden Did In Entire Term

Donald Trump has already answered more questions in his cabinet meetings than Joe Biden.

Trump has answered roughly 90 questions throughout 3 cabinet meetings.

Joe Biden answered only 5 questions from the press during cabinet meetings for his entire term.

Washington Times reported:

President Trump answered nearly 100 questions from the press during his first three Cabinet meetings this year — nearly 20 times the number answered by President Biden in the same setting during four years in office, according to data compiled by The Washington Times.

Mr. Trump fielded roughly 20 questions from the press during his third Cabinet meeting Thursday. He answered a whopping 55 questions during his first Cabinet meeting in February and 15 questions during his second meeting last month.

That brings the total number of questions Mr. Trump has answered during his Cabinet meetings, which have lasted between an hour and an hour and a half, to roughly 90.

In contrast, Mr. Biden answered a total of five press questions over the course of nine Cabinet meetings during his term. Mr. Biden spoke during the public portion of all his Cabinet meetings for a total of 45 minutes, or 5 minutes per meeting. He never spoke for longer than 7 minutes during any of the public portions of Cabinet meetings while in office.

Karoline Leavitt said, “As I’ve said before, and I will say it again today, everybody in this room has access to the most transparent and accessible president in American history.”

Fox News reported:

White House press secretary Karoline Leavitt touted the clear distinction between the presidents as a sign of transparency as she spoke to reporters at Friday’s press briefing.

“As I’ve said before, and I will say it again today, everybody in this room has access to the most transparent and accessible president in American history,” she said. “The Cabinet meeting yesterday was further proof.”

Most transparent President in history!

Posted on

Trump Effect: Wholesale Prices Drop

Wholesale prices dropped more than expected in March.

The Producer Price Index dropped .4% in March – it was expected to rise by .2%.

CNBC reported:

Wholesale prices unexpectedly fell in March, setting up a favorable inflation backdrop as President Donald Trump began intensifying tariffs against U.S. trading partners, the Bureau of Labor Statistics reported Friday.

The producer price index, considered a leading indicator for pipeline inflation pressures, declined a seasonally adjusted 0.4% for the month, after rising 0.1% in February. Economists surveyed by Dow Jones had been looking for an increase of 0.2%.

Excluding food and energy, so-called core PPI also declined, down 0.1% against the estimate for a 0.3% increase. The index less food, energy and trade services increased 0.1%.

This comes after the consumer price index also fell in March.

Epoch Times reported:

According to the Bureau of Labor Statistics, the annual inflation rate declined to 2.4 percent from 2.8 percent in February, the lowest reading since September 2024.
Economists had penciled in a reading of 2.6 percent.

On a monthly basis, the consumer price index (CPI) fell by a better-than-expected 0.1 percent.

Core inflation, which excludes volatile energy and food prices, also eased to 2.8 percent. This is the first time that annual core inflation has been below 3 percent since early 2021.

Donald Trump is keeping his promises to the American people.

Posted on

Pharma Company Announces Big Investment Into United States

The Swiss Pharmaceutical company Novartis is planning on building seven facilities and expanding investment in the United States amid Donald Trump’s tariff announcements.

Six of the facilities will be manufacturing plants.

Breitbart reported:

Pharmaceutical company Novartis announced plans to build seven facilities in the United States and expand others in a $23 billion investment over five years on the heels of President Donald Trump’s announcement of forthcoming tariffs on imported drugs.

Six of the facilities will be manufacturing plants, two of which will focus on radioligand therapy in Florida and Texas. It remains to be seen where the other four plants will be built.

Moreover, the company is establishing a biomedical research innovation center in San Diego as part of the investment, and it is expanding three of its production facilities in Indiana, New Jersey, and California.

In a press release, Novartis said, “Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over 5 years in US-based infrastructure, ensuring all key Novartis medicines for US patients will be made in the United States.”

Press Release:

Today, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over 5 years in US-based infrastructure, ensuring all key Novartis medicines for US patients will be made in the United States. This commitment enables Novartis to expand on its current manufacturing, research and technology presence across the country with 10 facilities, including 7 brand new facilities, creating nearly 1,000 new jobs at Novartis and approximately 4,000 additional US jobs. The production capacity will cover both active pharmaceutical ingredients (API) and biologics drug substance, as well as secondary production and packaging.

Over the next 5 years, Novartis will:

Establish 1 biomedical research innovation hub in San Diego, CA, its second global R&D hub in the US

Build 4 new manufacturing facilities in soon-to-be-determined states, including 3 that will make biologics drug substances, drug products, device assembly and packaging, and 1 facility that will make chemical drug substances, oral solids dosage forms and packaging

Build 2 new radioligand therapy (RLT) manufacturing facilities in Florida and Texas

Expand 3 RLT manufacturing facilities in Indianapolis, IN, Millburn, NJ, and Carlsbad, CA

With these investments, Novartis will have manufacturing capacity in the US for all its core technology platforms, including small molecules and biologics. Novartis already manufactures its most innovative, advanced therapies in the US for patients in the US and around the world. This includes cutting-edge technology platforms like gene and cell therapy and RLT manufacturing. This new investment will bring internal manufacturing of the company’s siRNA technology to the US for the first time and reflects a commitment to increase US manufacturing across its main therapeutic areas: oncology, immunology, neuroscience, and cardiovascular, renal and metabolic. With new manufacturing capacity, Novartis will be able to produce 100% of its key medicines end-to-end in the US, a significant increase from current levels.

“As a Swiss-based company with a significant presence in the US, these investments will enable us to fully bring our supply chain and key technology platforms into the US to support our strong US growth outlook. These investments also reflect the pro-innovation policy and regulatory environment in the US that supports our ability to find the next medical breakthroughs for patients,” said Vas Narasimhan, CEO of Novartis. “We are prepared for shifts in the external environment and fully confident in our 2025 guidance, mid- to long-term sales growth outlook and 2027 core margin guidance of 40%+.”

The investment includes a newly planned $1.1 billion research hub in San Diego, a state-of-the-art research facility that will provide world-class scientific infrastructure and drug discovery capabilities to enhance and strengthen the efforts of Novartis scientists working to reimagine the future of medicine. The new complex, expected to open between 2028 and 2029, will serve as the epicenter of the Novartis West Coast Biomedical Research presence, complementing existing hubs in Cambridge, MA, and Basel, Switzerland.

In addition, the company will be expanding RLT manufacturing with new facilities in Florida and Texas. Novartis is the only organization with a dedicated commercial RLT portfolio, and has established global expertise, with specialized supply chain and manufacturing capabilities across its network of RLT production facilities. To support growing demand for RLTs in the US, Novartis has already expanded production capabilities in Millburn, NJ, and a state-of-the-art facility in Indianapolis, IN, and is currently building a third US RLT manufacturing facility in Carlsbad, CA.

The US is a priority market for Novartis, and the company has taken numerous steps over its 200-year history to build its US infrastructure. Over the next 5 years, the total investment in Novartis US operations is expected to be nearly $50 billion, marking a clear demonstration of the company’s focus on the US.

Donald Trump’s agenda is working.

Posted on

Trump Revokes Security Clearance From Former CISA Director

Donald Trump revoked the security clearance of former Director of the Cybersecurity and Infrastructure Security Agency, Chris Krebs.

Trump called him a “fraud” and “disgrace.”

Breitbart reported:

President Donald Trump signed a Presidential Memorandum revoking the security clearance of former Director of the Cybersecurity and Infrastructure Security Agency (CISA), Chris Krebs.

While Trump signed various executive orders in the Oval Office on Wednesday, White House staff secretary Will Scharf explained to Trump that the Presidential Memorandum regarding Krebs “addresses his access to government existing clearances he might have.”

“I don’t know that I met him. I’m sure I met him, but I didn’t know him, and he came out right after the election — which was a rigged election, a badly rigged election. We did phenomenally in that election,” Trump said. “Look what happened to our country because of it — open borders, millions of people coming into our country. Russia and Ukraine, that would have never happened; October 7th would’ve never happened. Afghanistan, they way they withdraw, 13 dead, but so many killed. I mean, so many, so many killed outside of the 13 soldiers. Hundreds of people killed. And, maybe, I don’t know, never mentioned, but I mentioned it, 42 or 43 people so badly injured, the legs, the arms, blown off, the face, and this is all because of a incompetent group of people that preceded us. And, that would’ve never happened, and this guy Krebs was saying, ‘Oh, the election was great, it was great.’”

The order also calls for an investigation into Krebs and ex-DHS official Miles Taylor.

Axios reported:

Zoom in: The order calls for the Department of Justice to investigate both officials’ activities as government employees and also temporarily revokes the clearances held by any of their known associates.

For Taylor, the order specifically calls out any security clearance for individuals at the University of Pennsylvania, where Taylor is a lecturer, “pending a review of whether such clearances are consistent with the national interest,” according to the White House.

For Krebs, the security clearances include any given to staff at cybersecurity company SentinelOne, where Krebs currently works.

Krebs’ DOJ investigation will include “a comprehensive evaluation of all of CISA’s activities over the last 6 years and will identify any instances where Krebs’ or CISA’s conduct appears to be contrary to the administration’s commitment to free speech and ending federal censorship,” according to the order.

Trump is investigating the Deep State.